NO20053677L - Fremgangsmate for fremstilling av albumin - Google Patents

Fremgangsmate for fremstilling av albumin

Info

Publication number
NO20053677L
NO20053677L NO20053677A NO20053677A NO20053677L NO 20053677 L NO20053677 L NO 20053677L NO 20053677 A NO20053677 A NO 20053677A NO 20053677 A NO20053677 A NO 20053677A NO 20053677 L NO20053677 L NO 20053677L
Authority
NO
Norway
Prior art keywords
stabilizer
optionally
albumin
albumin solution
groups
Prior art date
Application number
NO20053677A
Other languages
English (en)
Other versions
NO20053677D0 (no
Inventor
Werner Gehringer
Katharina Pock
Tor-Einar Svae
Christoph Kannicht
Juergen Romisch
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20053677D0 publication Critical patent/NO20053677D0/no
Publication of NO20053677L publication Critical patent/NO20053677L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives et terapeutisk anvendelig virusinaktivert albumin og en fremgangsmåte for fremstilling av terapeutisk anvendelig virusinaktiverte albuminer som kjennetegnes ved kombinasjonen av følgende trinn: (a) underkastelse av en første vandig albuminløsning en behandling for virusinaktivering etter SD-metoden gjennom kontakt med SD-reagenser ved en temperatur under 45°C, (b) fjerning av SD-reagensene ved oljeekstraksjon og påfølgende hydrofob interaksjonskromatografi, i det minste i det vesentlige, hvorunder det under kromatograferingen benyttes en hydrofob matriks, særlig en matriks som eventuelt hydrofobe grupper kan være bundet til, under den forutsetning at disse gruppene er alifatiske grupper med C>24, og hvor det oppnås en andre albuminløsning, som (c) eventuelt tilsettes én eller flere stabilisatorer innen gruppen sukker, aminosyrer og sukkeralkoholer, under forutsetning av at det som stabilisator ikke benyttes noen indol-stabilisator og ingen C6-C10-fettsyre, hvoretter (d) den andre, eventuelt stabilisator-tilsatte, albuminiøsning, sluttbehandles og sterilfiltreres og eventuelt påfylles den endelige beholder.
NO20053677A 2003-02-13 2005-07-29 Fremgangsmate for fremstilling av albumin NO20053677L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT2182003 2003-02-13
PCT/EP2004/001397 WO2004071524A1 (de) 2003-02-13 2004-02-13 Albuminlösung und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO20053677D0 NO20053677D0 (no) 2005-07-29
NO20053677L true NO20053677L (no) 2005-10-31

Family

ID=32854882

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053677A NO20053677L (no) 2003-02-13 2005-07-29 Fremgangsmate for fremstilling av albumin

Country Status (22)

Country Link
EP (1) EP1592439B1 (no)
JP (1) JP2006517938A (no)
KR (1) KR20050103292A (no)
CN (1) CN100384471C (no)
AT (1) ATE362376T1 (no)
AU (1) AU2004212324B2 (no)
BR (1) BRPI0407458A (no)
CA (1) CA2514163A1 (no)
CY (1) CY1106793T1 (no)
DE (1) DE502004003834D1 (no)
DK (1) DK1592439T3 (no)
ES (1) ES2285427T3 (no)
IL (1) IL169828A0 (no)
MX (1) MXPA05008276A (no)
NO (1) NO20053677L (no)
PL (1) PL376644A1 (no)
PT (1) PT1592439E (no)
RS (1) RS50891B (no)
RU (1) RU2305556C2 (no)
UA (1) UA80469C2 (no)
WO (1) WO2004071524A1 (no)
ZA (1) ZA200506452B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005023155A1 (de) * 2005-05-13 2006-11-16 Albutec Gmbh Albuminlösung
KR20080078010A (ko) * 2005-12-22 2008-08-26 체에스엘 베링 게엠베하 옥타노에이트-감소된 사람 알부민
ES2332846B1 (es) 2007-10-26 2010-07-08 Grifols, S.A. Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
EP2382993A1 (en) 2010-04-19 2011-11-02 KTB Tumorforschungsgesellschaft mbH Combination of drugs with protein-binding prodrugs
CN111195351A (zh) * 2020-01-20 2020-05-26 华兰生物工程重庆有限公司 5%低浓度人血白蛋白的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2190436B1 (no) * 1972-07-05 1975-06-20 Merieux Inst
SU1212416A1 (ru) * 1984-04-03 1986-02-23 Научно-Исследовательский Институт Гематологии И Переливания Крови Им.Проф.Р.О.Еоляна Способ выделени альбумина из плазмы крови
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
RU2007423C1 (ru) * 1991-06-04 1994-02-15 Институт биофизики клетки РАН Способ очистки сывороточного альбумина
DE19729778A1 (de) * 1997-07-11 1999-01-21 Blutspendedienst Der Drk Lande Verfahren zur Herstellung von virusinaktivierten biologischen Flüssigkeiten
US5919907A (en) * 1997-12-22 1999-07-06 Shanbrom Technologies Llc Preparation and utilization of a novel sterile albumin
IL136552A (en) * 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration

Also Published As

Publication number Publication date
PT1592439E (pt) 2007-06-22
MXPA05008276A (es) 2006-03-21
CY1106793T1 (el) 2012-05-23
DE502004003834D1 (de) 2007-06-28
NO20053677D0 (no) 2005-07-29
IL169828A0 (en) 2011-08-01
RS50891B (sr) 2010-08-31
JP2006517938A (ja) 2006-08-03
ATE362376T1 (de) 2007-06-15
ES2285427T3 (es) 2007-11-16
BRPI0407458A (pt) 2006-01-31
AU2004212324A1 (en) 2004-08-26
CN1798573A (zh) 2006-07-05
EP1592439A1 (de) 2005-11-09
ZA200506452B (en) 2007-01-31
WO2004071524A1 (de) 2004-08-26
AU2004212324B2 (en) 2009-05-07
EP1592439B1 (de) 2007-05-16
CA2514163A1 (en) 2004-08-26
CN100384471C (zh) 2008-04-30
KR20050103292A (ko) 2005-10-28
DK1592439T3 (da) 2007-09-10
RU2305556C2 (ru) 2007-09-10
RS20050624A (sr) 2007-06-04
PL376644A1 (pl) 2006-01-09
UA80469C2 (en) 2007-09-25
RU2005128507A (ru) 2006-01-20

Similar Documents

Publication Publication Date Title
CN104042548B (zh) 一种蜗牛黏液提取物及其制备方法和在化妆品中的应用
CN105886583A (zh) 一种牛骨髓肽提取方法
NO20053677L (no) Fremgangsmate for fremstilling av albumin
BR112023004624A2 (pt) Processo para preparar um produto à base de plantas fermentado contendo proteína
JP2017521451A (ja) 微細藻類バイオマスから可溶性タンパク質を抽出するための方法
Li et al. A review on current downstream bio-processing technology of vaccine products
CN111965371A (zh) 一种蛋白印迹膜抗体剥离液的配方及其制备和使用方法
CN105732820B (zh) 一种重组人胰岛素原融合蛋白的复性方法
KR880012753A (ko) 활성적인 형태의 단백질 제조방법
PL1654284T3 (pl) Sposób uzyskiwania roztworu alfa-1-antytrypsyny
Jain et al. Review on isolation and purification of papain enzyme from papaya fruit
KR20160134657A (ko) 미세조류 바이오매스의 열 투과화를 위한 방법
JP7454507B2 (ja) ボツリヌス毒素の製造方法
ATE226613T1 (de) Verfahren zur extraktion von lycopin
IL86417A (en) Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
CN106086132A (zh) 一种利用银杏果皮制备抗氧化肽的方法
WO2021260041A3 (en) Method for separation of potato proteins with reduced enzymatic activity from potato fruit juice
CN102993290B (zh) 反胶团法分离萃取鱼精蛋白
Templin et al. Membrane separation of solids from corn processing streams
Altuner A predictive modelling study for using high hydrostatic pressure, a food processing technology, for protein extraction
ATE221323T1 (de) Verfahren zur herstellung eines eiweissisolats aus einer eiweisshaltigen substanz
Islam et al. Enzyme processing of soy flour with minimized protein loss
SE0100801L (sv) Metod för förbehandling av mjölk vid mikrofiltrering
JP2006104461A (ja) グリコサミノグリカン画分中の不純物の除去方法
CN106883307A (zh) 一种灰树花水提多糖和碱提多糖分离纯化的方法

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application